TrialNEO100 and High-Grade Meningioma
Trial details
- Registry ID
- NCT05023018
- Phase
- Phase 2
NTHI
Neonc Technologies, Inc.
Company identity has not yet been verified
Browse linked trials and recorded changes, or follow this company for updates.
1Trials in this database
1Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
Completion dates · Pro
Which trial dates moved later?
Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
Included trials
Check company identity source| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| NEO100 and High-Grade MeningiomaNCT05023018 | Neonc Technologies, Inc. | Phase 2 | Recruiting | 2026-12-30Estimated |
Latest recorded trial changes
NEO100 and High-Grade Meningioma
NCT05023018 · Neonc Technologies, Inc.
Primary completion date changed
− Before
30 Sep 2025
+ After
30 Dec 2026